Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Knowler

Showing results (221-230 of 345) with videos related to

Pageof 35
Sort By:
American Journal of Nephrology|September 22, 2017
Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 DiabetesPierre-Jean Saulnier, Brad P Dieter, Stephanie K Tanamas, et al.
Diabetes|January 7, 2018
Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224-3231E Jennifer Weil, Gudeta Fufaa, Lois I Jones, et al.
Diabetes|April 3, 2013
Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetesE Jennifer Weil, Gudeta Fufaa, Lois I Jones, et al.
Hypertension (Dallas, Tex. : 1979)|September 29, 2004
Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima IndiansPaul W Franks, William C Knowler, Saras Nair, et al.
Clinical Trials (London, England)|September 10, 2009
Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trialsDavid L Mount, Patricia Feeney, Anthony N Fabricatore, et al.
Diabetes Care|September 13, 2022
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program ExperienceNeil H White, Qing Pan, William C Knowler, et al.
Journal of the American Geriatrics Society|December 3, 2020
Impact of an 8-Year Intensive Lifestyle Intervention on an Index of MultimorbidityMark A Espeland, Sarah A Gaussoin, Judy Bahnson, et al.
Diabetes Care|May 2, 2025
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS ExperienceNeil H White, Qing Pan, William C Knowler, et al.
European Journal of Human Genetics : EJHG|June 10, 2022
Functional characterization of a novel p.Ser76Thr variant in IGFBP4 that associates with body mass index in American IndiansYunhua L Muller, Michael Saporito, Samantha Day, et al.
Circulation. Cardiovascular Genetics|November 19, 2015
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEADL Maria Belalcazar, George D Papandonatos, Bahar Erar, et al.
Pageof 35

Showing results (221-230 of 345) with videos related to

Sort By:
Pageof 35
American Journal of Nephrology|September 22, 2017
Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 DiabetesPierre-Jean Saulnier, Brad P Dieter, Stephanie K Tanamas, et al.
Diabetes|January 7, 2018
Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224-3231E Jennifer Weil, Gudeta Fufaa, Lois I Jones, et al.
Diabetes|April 3, 2013
Effect of losartan on prevention and progression of early diabetic nephropathy in American Indians with type 2 diabetesE Jennifer Weil, Gudeta Fufaa, Lois I Jones, et al.
Hypertension (Dallas, Tex. : 1979)|September 29, 2004
Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima IndiansPaul W Franks, William C Knowler, Saras Nair, et al.
Clinical Trials (London, England)|September 10, 2009
Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trialsDavid L Mount, Patricia Feeney, Anthony N Fabricatore, et al.
Diabetes Care|September 13, 2022
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program ExperienceNeil H White, Qing Pan, William C Knowler, et al.
Journal of the American Geriatrics Society|December 3, 2020
Impact of an 8-Year Intensive Lifestyle Intervention on an Index of MultimorbidityMark A Espeland, Sarah A Gaussoin, Judy Bahnson, et al.
Diabetes Care|May 2, 2025
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS ExperienceNeil H White, Qing Pan, William C Knowler, et al.
European Journal of Human Genetics : EJHG|June 10, 2022
Functional characterization of a novel p.Ser76Thr variant in IGFBP4 that associates with body mass index in American IndiansYunhua L Muller, Michael Saporito, Samantha Day, et al.
Circulation. Cardiovascular Genetics|November 19, 2015
Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEADL Maria Belalcazar, George D Papandonatos, Bahar Erar, et al.
Pageof 35